{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2026:FX3MKW7SZEBC44VQI623GVBORB","short_pith_number":"pith:FX3MKW7S","schema_version":"1.0","canonical_sha256":"2df6c55bf2c9022e72b047b5b3542e8845dd6324194dfadb149fea07d673769c","source":{"kind":"arxiv","id":"2605.23246","version":1},"attestation_state":"computed","paper":{"title":"Regulatory Considerations for Using Artificial Intelligence Models to Reduce Sample Sizes in Registrational Studies","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Aaron M. Smith, Jonathan R. Walsh, Run Zhuang, Tala Fakhouri","submitted_at":"2026-05-22T05:30:06Z","abstract_excerpt":"Applications of artificial intelligence (AI) in drug development continue to increase at a rapid pace. Regulatory authorities have provided increasingly clear perspectives on the use of AI in regulated applications, including recent draft guidance from FDA that provides a 7-step risk-based framework to assess AI model credibility for these cases. We present an application of AI models to prospectively reduce the planned sample size in a randomized controlled trial, using model-derived prognostic covariates. This can shorten trial timelines, enable faster decision making, and lower costs. When "},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2605.23246","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2026-05-22T05:30:06Z","cross_cats_sorted":[],"title_canon_sha256":"69cfcb3e4b2411a08414e3ce96f1652581f18ce500930b429449223e1554c60f","abstract_canon_sha256":"785e6e62074ba4f49443bae5343c80e67e3271f291cfa2de1fca7a520bdacb1c"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-25T02:01:45.526743Z","signature_b64":"2gOqVx+JGSaRGw+RSxeWwZTgAv78jtAh0XHWZnk6ih7ytRnGd2fiCin8c/575bdq9zXnqVbMhhARv00pPpM+BQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"2df6c55bf2c9022e72b047b5b3542e8845dd6324194dfadb149fea07d673769c","last_reissued_at":"2026-05-25T02:01:45.526199Z","signature_status":"signed_v1","first_computed_at":"2026-05-25T02:01:45.526199Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Regulatory Considerations for Using Artificial Intelligence Models to Reduce Sample Sizes in Registrational Studies","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Aaron M. Smith, Jonathan R. Walsh, Run Zhuang, Tala Fakhouri","submitted_at":"2026-05-22T05:30:06Z","abstract_excerpt":"Applications of artificial intelligence (AI) in drug development continue to increase at a rapid pace. Regulatory authorities have provided increasingly clear perspectives on the use of AI in regulated applications, including recent draft guidance from FDA that provides a 7-step risk-based framework to assess AI model credibility for these cases. We present an application of AI models to prospectively reduce the planned sample size in a randomized controlled trial, using model-derived prognostic covariates. This can shorten trial timelines, enable faster decision making, and lower costs. When "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2605.23246","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2605.23246/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2605.23246","created_at":"2026-05-25T02:01:45.526256+00:00"},{"alias_kind":"arxiv_version","alias_value":"2605.23246v1","created_at":"2026-05-25T02:01:45.526256+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2605.23246","created_at":"2026-05-25T02:01:45.526256+00:00"},{"alias_kind":"pith_short_12","alias_value":"FX3MKW7SZEBC","created_at":"2026-05-25T02:01:45.526256+00:00"},{"alias_kind":"pith_short_16","alias_value":"FX3MKW7SZEBC44VQ","created_at":"2026-05-25T02:01:45.526256+00:00"},{"alias_kind":"pith_short_8","alias_value":"FX3MKW7S","created_at":"2026-05-25T02:01:45.526256+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB","json":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB.json","graph_json":"https://pith.science/api/pith-number/FX3MKW7SZEBC44VQI623GVBORB/graph.json","events_json":"https://pith.science/api/pith-number/FX3MKW7SZEBC44VQI623GVBORB/events.json","paper":"https://pith.science/paper/FX3MKW7S"},"agent_actions":{"view_html":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB","download_json":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB.json","view_paper":"https://pith.science/paper/FX3MKW7S","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2605.23246&json=true","fetch_graph":"https://pith.science/api/pith-number/FX3MKW7SZEBC44VQI623GVBORB/graph.json","fetch_events":"https://pith.science/api/pith-number/FX3MKW7SZEBC44VQI623GVBORB/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB/action/timestamp_anchor","attest_storage":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB/action/storage_attestation","attest_author":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB/action/author_attestation","sign_citation":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB/action/citation_signature","submit_replication":"https://pith.science/pith/FX3MKW7SZEBC44VQI623GVBORB/action/replication_record"}},"created_at":"2026-05-25T02:01:45.526256+00:00","updated_at":"2026-05-25T02:01:45.526256+00:00"}